HI
INDV icon

Horizon Investments’s Indivior Pharmaceuticals INDV Stock Holding History

Horizon Investments’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
25,390
-3,157
-11% -$115K 0.01% 719
2026
Q1 		$870K Buy
+28,547
New +$943K 0.01% 695

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Horizon Investments's INDV Position: Q2 2026 in Review

Horizon Investments reduced its Indivior Pharmaceuticals (INDV) stake by 11% in Q2 2026, selling an estimated $115K and leaving 25,390 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #719.

Horizon Investments first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Horizon Investments held 25,390 shares of Indivior Pharmaceuticals worth $1.04M as of Q2 2026.
  • Horizon Investments sold 3,157 Indivior Pharmaceuticals shares in Q2 2026, an estimated $115K.
  • Indivior Pharmaceuticals made up 0.01% of Horizon Investments's portfolio in Q2 2026, its #719 holding.
  • Horizon Investments first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.